<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="of human and veterinary medical importance. The novel coronavirus, severe" exact="acute" post="respiratory symptoms coronavirus 2 (SARS-CoV-2), associated with the current"/>
 <result pre="human and veterinary medical importance. The novel coronavirus, severe acute" exact="respiratory" post="symptoms coronavirus 2 (SARS-CoV-2), associated with the current global"/>
 <result pre="coronaviruses with a focus on antiviral immune responses in the" exact="respiratory" post="and intestinal tracts to infection with severe coronaviruses that"/>
 <result pre="antiviral immune responses in the respiratory and intestinal tracts to" exact="infection" post="with severe coronaviruses that have caused epidemic diseases in"/>
 <result pre="the potential development of coronavirus vaccines and antiviral drugs. coronaviruses" exact="viral" post="tissue tropism antiviral immune response interferon signaling immune evasion"/>
 <result pre="have caused major public health threats, such as the severe" exact="acute" post="respiratory symptom (SARS) outbreak in 2002âˆ’2003 [1], and Middle"/>
 <result pre="caused major public health threats, such as the severe acute" exact="respiratory" post="symptom (SARS) outbreak in 2002âˆ’2003 [1], and Middle East"/>
 <result pre="respiratory symptom (SARS) outbreak in 2002âˆ’2003 [1], and Middle East" exact="respiratory" post="syndrome coronavirus (MERS), which emerged in 2012 [2]. At"/>
 <result pre="symptom (SARS) outbreak in 2002âˆ’2003 [1], and Middle East respiratory" exact="syndrome" post="coronavirus (MERS), which emerged in 2012 [2]. At the"/>
 <result pre="very beginning of this new decade, a novel coronavirus, severe" exact="acute" post="respiratory symptoms coronavirus 2 (SARS-CoV-2), emerged and caused a"/>
 <result pre="beginning of this new decade, a novel coronavirus, severe acute" exact="respiratory" post="symptoms coronavirus 2 (SARS-CoV-2), emerged and caused a catastrophic"/>
 <result pre="coronavirus 2 (SARS-CoV-2), emerged and caused a catastrophic pandemic of" exact="respiratory" post="illness worldwide. During the period from December 2019 to"/>
 <result pre="a fundamental process involved in the innate immune response to" exact="viral infection." post="These soluble antiviral cytokines can induce upregulation of an"/>
 <result pre="PKR, and ISG15, which have antiviral activity as they halt" exact="viral" post="replication and dissemination of infected cells [4]. Thus, before"/>
 <result pre="protecting tissue damage and inflammation at the early phase of" exact="infection" post="[5]. However, recent studies revealed that excessive expression of"/>
 <result pre="infection [5]. However, recent studies revealed that excessive expression of" exact="type I" post="and III IFNs might disrupt the repair of lung"/>
 <result pre="I and III IFNs might disrupt the repair of lung" exact="epithelial" post="tissue during respiratory viral infection [6,7,8]. Indeed, coronaviruses are"/>
 <result pre="IFNs might disrupt the repair of lung epithelial tissue during" exact="respiratory" post="viral infection [6,7,8]. Indeed, coronaviruses are known to efficiently"/>
 <result pre="might disrupt the repair of lung epithelial tissue during respiratory" exact="viral infection" post="[6,7,8]. Indeed, coronaviruses are known to efficiently circumvent the"/>
 <result pre="disrupt the repair of lung epithelial tissue during respiratory viral" exact="infection" post="[6,7,8]. Indeed, coronaviruses are known to efficiently circumvent the"/>
 <result pre="can barely be detected during the early phase of coronavirus" exact="infection" post="[9,10]. Compared with SARS and MERS, COVID-19 patients have"/>
 <result pre="[13]. It has to be mentioned that IFN-antagonistic functions affect" exact="viral" post="virulence to a considerable extent and might be associated"/>
 <result pre="Therefore, in this review, we summarize antiviral immunity in the" exact="respiratory" post="and intestinal tracts against coronaviruses that have been reported"/>
 <result pre="immune surveillance exerted by the host. 2. Coronavirus Taxonomy and" exact="Viral" post="Tissue Tropism Coronaviruses, members of the family Coronaviridae, have"/>
 <result pre="natural reservoirs of coronaviruses, and they transmit them to the" exact="intermediate" post="hosts of camelids, civets, dromedary camels, pangolins, or domestic"/>
 <result pre="in humans, such as SARS and MERS [19]. Recently, a" exact="pneumonia" post="outbreak by SARS-CoV-2 was thought to have originated in"/>
 <result pre="Alphacoronaviruses, which mainly include human CoV-229E, human CoV-NL63, porcine epidemic" exact="diarrhea" post="virus (PEDV), and transmissible gastroenteritis virus (TGEV); (b) Betacoronaviruses,"/>
 <result pre="CoV-229E, human CoV-NL63, porcine epidemic diarrhea virus (PEDV), and transmissible" exact="gastroenteritis" post="virus (TGEV); (b) Betacoronaviruses, which mainly include severe acute"/>
 <result pre="transmissible gastroenteritis virus (TGEV); (b) Betacoronaviruses, which mainly include severe" exact="acute" post="respiratory symptoms coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus"/>
 <result pre="gastroenteritis virus (TGEV); (b) Betacoronaviruses, which mainly include severe acute" exact="respiratory" post="symptoms coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV),"/>
 <result pre="mainly include severe acute respiratory symptoms coronavirus (SARS-CoV), Middle East" exact="respiratory" post="syndrome coronavirus (MERS-CoV), severe acute respiratory symptoms coronavirus 2"/>
 <result pre="include severe acute respiratory symptoms coronavirus (SARS-CoV), Middle East respiratory" exact="syndrome" post="coronavirus (MERS-CoV), severe acute respiratory symptoms coronavirus 2 (SARS-CoV-2),"/>
 <result pre="symptoms coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV), severe" exact="acute" post="respiratory symptoms coronavirus 2 (SARS-CoV-2), mouse hepatitis virus (MHV),"/>
 <result pre="coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV), severe acute" exact="respiratory" post="symptoms coronavirus 2 (SARS-CoV-2), mouse hepatitis virus (MHV), and"/>
 <result pre="coronavirus (MERS-CoV), severe acute respiratory symptoms coronavirus 2 (SARS-CoV-2), mouse" exact="hepatitis" post="virus (MHV), and bovine CoV (BCoV); (c) Gammacoronaviruses are"/>
 <result pre="CoV (BCoV); (c) Gammacoronaviruses are related to avian diseases, including" exact="infectious" post="bronchitis virus (IBV) and turkey blue comb virus (TBV);"/>
 <result pre="(BCoV); (c) Gammacoronaviruses are related to avian diseases, including infectious" exact="bronchitis" post="virus (IBV) and turkey blue comb virus (TBV); (d)"/>
 <result pre="(IBV) and turkey blue comb virus (TBV); (d) Deltacoronaviruses. Generally," exact="Alpha" post="and Betacoronaviruses invade mammalian hosts, whereas Gammacoronaviruses infect avian"/>
 <result pre="susceptible target cells of the host species and presents distinct" exact="viral" post="tissue tropism [24]. Coronaviruses infecting mammalian animals principally cause"/>
 <result pre="mammalian animals principally cause histopathological lesions in the intestinal and" exact="respiratory" post="tracts, but in some cases, they cause central neurologic"/>
 <result pre="humans, coronaviruses have been proven to be mainly associated with" exact="respiratory" post="illnesses [17]. Specifically, the mouse hepatitis coronavirus and feline"/>
 <result pre="be mainly associated with respiratory illnesses [17]. Specifically, the mouse" exact="hepatitis" post="coronavirus and feline coronavirus can cause pneumonia and gastrointestinal"/>
 <result pre="Specifically, the mouse hepatitis coronavirus and feline coronavirus can cause" exact="pneumonia" post="and gastrointestinal infections as well as hepatitis and neurologic"/>
 <result pre="hepatitis coronavirus and feline coronavirus can cause pneumonia and gastrointestinal" exact="infections" post="as well as hepatitis and neurologic disorders. It has"/>
 <result pre="coronavirus can cause pneumonia and gastrointestinal infections as well as" exact="hepatitis" post="and neurologic disorders. It has been indicated that the"/>
 <result pre="The dipeptidyl peptidase-4 (DPP4) receptor is associated with MERS-CoV in" exact="respiratory" post="organs [26], whereas aminopeptidase N (APN) is the functional"/>
 <result pre="the S protein for membrane fusion in SARS-CoV and SARS-CoV-2" exact="infection" post="[30]. Notably, ACE2 and TMPRSS2 are also highly expressed"/>
 <result pre="that the digestive system is a potential route for SARS-CoV-2" exact="infection" post="[33,34]. 3. Antiviral Immune Responses to Coronavirus Infection The"/>
 <result pre="for SARS-CoV-2 infection [33,34]. 3. Antiviral Immune Responses to Coronavirus" exact="Infection" post="The respiratory and intestinal tracts are crucial opening windows"/>
 <result pre="infection [33,34]. 3. Antiviral Immune Responses to Coronavirus Infection The" exact="respiratory" post="and intestinal tracts are crucial opening windows of the"/>
 <result pre="The mucus gel forms a continuous layer on the mucosal" exact="epithelial" post="surface of the respiratory and intestinal tracts (Figure 1)"/>
 <result pre="a continuous layer on the mucosal epithelial surface of the" exact="respiratory" post="and intestinal tracts (Figure 1) and provides an essential"/>
 <result pre="by goblet cells are the main component of airway/intestinal mucus." exact="Respiratory" post="mucus can be divided into two discreet layers, a"/>
 <result pre="components of innate immunity that limit the severity of influenza" exact="virus infection," post="suggesting that mucins are an essential defense barrier against"/>
 <result pre="could interact with different sialic acid residues to modulate the" exact="infection" post="efficiency [40,41]. Moreover, the number of goblet cells was"/>
 <result pre="in the small intestine during the early phase of PEDV" exact="infection" post="[42], but studies focused on the interplay between different"/>
 <result pre="pattern-recognition receptors (PRRs). The PRRs involved in the detection of" exact="viral" post="pathogens mainly include toll-like receptors (TLRs), retinoic acid-inducible gene"/>
 <result pre="pathogens mainly include toll-like receptors (TLRs), retinoic acid-inducible gene (RIG)" exact="type I" post="like receptors (RLRs), C-type lectin-like receptors (CLRs), and nucleotide-binding"/>
 <result pre="(dsRNA), single-stranded RNA (ssRNA), and glycoproteins, can be recognized during" exact="viral infection" post="and replication via TLRs and RLRs, resulting in the"/>
 <result pre="single-stranded RNA (ssRNA), and glycoproteins, can be recognized during viral" exact="infection" post="and replication via TLRs and RLRs, resulting in the"/>
 <result pre="on the cellular membrane and endomembrane of various cells, including" exact="epithelial" post="cells, fibroblasts, macrophages, dendritic cells, B cells, and some"/>
 <result pre="surface of cells and are capable of detecting glycoproteins of" exact="viral" post="PAMPs (Figure 2). They have been identified as potential"/>
 <result pre="on the lung epithelium may act as a cofactor, affecting" exact="viral" post="entry [48], and it may play a protective role"/>
 <result pre="induces an effective host cell-intrinsic antiviral defense against lethal SARS-CoV" exact="infection" post="[50]. In contrast, TLRs 7 and 8 of plasmacytoid"/>
 <result pre="the adaptor protein myeloid differentiation factor 88 (MyD88) during the" exact="viral infection" post="[51]. A previous study indicated that pDCs control the"/>
 <result pre="adaptor protein myeloid differentiation factor 88 (MyD88) during the viral" exact="infection" post="[51]. A previous study indicated that pDCs control the"/>
 <result pre="that pDCs control the fast replication of MHV through TLR7-mediated" exact="type I" post="IFN production [52]. Interestingly, a recent study using a"/>
 <result pre="proinflammatory response [53]. Nevertheless, whether pDCs are essential for controlling" exact="viral infection" post="still needs to be tested in SARS-CoV-2 patients. Moreover,"/>
 <result pre="response [53]. Nevertheless, whether pDCs are essential for controlling viral" exact="infection" post="still needs to be tested in SARS-CoV-2 patients. Moreover,"/>
 <result pre="transcriptional factors of IRFs 1/3/7 could trigger the transcription of" exact="Type I" post="IFNs (IFN-Î±/Î²) and Type III IFNs (IFN-Î») [45], while"/>
 <result pre="could trigger the transcription of Type I IFNs (IFN-Î±/Î²) and" exact="Type III" post="IFNs (IFN-Î») [45], while NF-ÎºB mediates the transcription of"/>
 <result pre="can be detected by both MDA5 and RIG-I, which induces" exact="Type I" post="IFN production in oligodendrocytes via the activation of the"/>
 <result pre="via the activation of the transcriptional factor IRF3 [57]. Meanwhile," exact="infection" post="with MHV activates MDA5 signaling, resulting in decreased levels"/>
 <result pre="effectively reduces the severity of MHV-induced pathogenesis [58]. Nevertheless, SARS-CoV" exact="infection" post="causes temporal and spatial activation of the transcriptional factor"/>
 <result pre="of proinflammatory cytokines at 12 h postinfection, whereas transcription of" exact="Type I" post="IFNs by IRF3/IRF7 is delayed until 48 h postinfection"/>
 <result pre="RNA intermediates that trigger TLR and RIG-I signaling during the" exact="viral" post="life cycle. 3.3. Cytokines Involved in Antiviral Innate Responses"/>
 <result pre="Antiviral Innate Responses The epithelium and immune cells in the" exact="respiratory" post="and intestinal tracts detect the invading virus via innate"/>
 <result pre="cytokines, chemokines, and ISGs, which protect the host cells from" exact="viral infection" post="during the early phase. However, patients with severe disease"/>
 <result pre="chemokines, and ISGs, which protect the host cells from viral" exact="infection" post="during the early phase. However, patients with severe disease"/>
 <result pre="viral infection during the early phase. However, patients with severe" exact="disease" post="who are infected with highly pathogenic viruses, such as"/>
 <result pre="IFNs can be expressed in many diverse cell types, whereas" exact="type III" post="IFNs are mainly produced in epithelial cells and dendritic"/>
 <result pre="cell types, whereas type III IFNs are mainly produced in" exact="epithelial" post="cells and dendritic cells [63]. Recently, it has become"/>
 <result pre="clear that despite the similarities between type Î™ IFN and" exact="type III" post="IFN signaling cascades, type III IFNs seem to specifically"/>
 <result pre="between type Î™ IFN and type III IFN signaling cascades," exact="type III" post="IFNs seem to specifically protect the epithelial cells from"/>
 <result pre="signaling cascades, type III IFNs seem to specifically protect the" exact="epithelial" post="cells from pathogen attacks and form a local special"/>
 <result pre="the type Î™ IFN apparatus is mobilized to mediate a" exact="systemic" post="antiviral immune response [65]. However, highly contagious coronaviruses have"/>
 <result pre="or delayed IFN responses may explain the progressive increase in" exact="viral" post="replication and immunopathology in SARS patients [68]. However, some"/>
 <result pre="recommended as potential therapeutic drugs to prevent and treat SARS-CoV-2" exact="infection" post="[70,71,72]. Notably, excessive and prolonged IFN expression might lead"/>
 <result pre="expression might lead to deleterious proinflammatory responses and may aggravate" exact="viral infection" post="by disrupting the lung epithelial barrier [7,8]. Thus, the"/>
 <result pre="might lead to deleterious proinflammatory responses and may aggravate viral" exact="infection" post="by disrupting the lung epithelial barrier [7,8]. Thus, the"/>
 <result pre="responses and may aggravate viral infection by disrupting the lung" exact="epithelial" post="barrier [7,8]. Thus, the dose, frequency, and duration of"/>
 <result pre="should be considered carefully before use in clinical practice against" exact="viral infection." post="3.3.2. Proinflammatory Cytokines SARS-CoV infection induces upregulation of proinflammatory"/>
 <result pre="in clinical practice against viral infection. 3.3.2. Proinflammatory Cytokines SARS-CoV" exact="infection" post="induces upregulation of proinflammatory cytokines/chemokines, such as interleukin (IL)-1Î²,"/>
 <result pre="of proinflammatory cytokines/chemokines, such as interleukin (IL)-1Î², IL-6, IL-8, IL-12," exact="monocyte" post="chemotactic protein 1 (MCP-1), and IFN-Î³ inducible protein (IP-10),"/>
 <result pre="and its associated proinflammatory pathway might be correlated with severe" exact="respiratory" post="disease [69]. To better understand the modulation of the"/>
 <result pre="its associated proinflammatory pathway might be correlated with severe respiratory" exact="disease" post="[69]. To better understand the modulation of the immune"/>
 <result pre="importance of the recruitment of neutrophils and monocytes in controlling" exact="viral infection" post="[68]. 3.3.3. Interferon-Stimulated Genes (ISGs) IFNs activate the kinases"/>
 <result pre="of the recruitment of neutrophils and monocytes in controlling viral" exact="infection" post="[68]. 3.3.3. Interferon-Stimulated Genes (ISGs) IFNs activate the kinases"/>
 <result pre="the surrounding uninfected cells [56,76]. This state can efficiently inhibit" exact="viral infection" post="and replication, and it also simultaneously induces priming of"/>
 <result pre="surrounding uninfected cells [56,76]. This state can efficiently inhibit viral" exact="infection" post="and replication, and it also simultaneously induces priming of"/>
 <result pre="ISGs known to exert direct antiviral activity are upregulated during" exact="viral infection," post="such as IFN-induced proteins with IFN-induced transmembrane proteins (IFITMs),"/>
 <result pre="is no clear correlation between the observed ISG upregulation and" exact="disease" post="severity [81]. The potential ISGs exert protective functions against"/>
 <result pre="exert protective functions against SARS-CoV-2 infection, which may explain the" exact="lower" post="proportion of severe cases and the lower case-fatality rate"/>
 <result pre="may explain the lower proportion of severe cases and the" exact="lower" post="case-fatality rate in COVID-19 patients compared with SARS cases"/>
 <result pre="COVID-19 patients compared with SARS cases [82]. However, a high" exact="viral" post="load has been detected at the very early phase"/>
 <result pre="has been detected at the very early phase of SARS-CoV-2" exact="infection" post="after symptom onset [83], suggesting that the novel emerging"/>
 <result pre="hours of infection, which greatly facilitates the establishment of productive" exact="viral" post="replication [9,10]. Coronaviruses employ multiple strategies to evade the"/>
 <result pre="RNA synthesis, modification at the 5â€²end with 2â€²-O methylation of" exact="viral" post="RNA, and inhibition of IFN signaling cascades. 4.1. Hijack"/>
 <result pre="CLRs, such as DC-specific intercellular adhesion molecule 3-grabbing nonintegrin (DC-SIGN)." exact="Viral" post="glycoproteins interact with DC-SIGN, which helps viruses to break"/>
 <result pre="interact with DC-SIGN, which helps viruses to break through the" exact="epithelial" post="barrier. Thus, they act as a â€œTrojan Horseâ€�, allowing"/>
 <result pre="are also crucial target cells of MERS-CoV that participate in" exact="viral" post="replication and dissemination [88]. Additionally, the SARS-CoV spike glycoprotein"/>
 <result pre="endoplasmic reticulum, which are thought to be associated with the" exact="viral" post="synthesis of positive-stranded RNA [90]. Coronaviruses, like all positive-stranded"/>
 <result pre="viruses, hijack endoplasmic reticulum membranes to form their headquarters for" exact="viral" post="RNA synthesis exclusively in the cytosol. A previous study"/>
 <result pre="(nsp) 3, 4, and 6 of SARS-CoV are specific hydrophobic" exact="viral" post="proteins that contain transmembrane domains for the formation of"/>
 <result pre="nsp4 can also mimic the formation of ROs, shielding their" exact="viral" post="dsRNA from innate immune sensors in the cytosol, such"/>
 <result pre="RIG-I [92]. Compared with the formation of convoluted membranes of" exact="Alpha" post="and Betacoronaviruses, the specific formation of a zippered endoplasmic"/>
 <result pre="with tethered double-membrane spherules was observed in the Gammacoronavirus avian" exact="infectious" post="bronchitis virus [93] and porcine Deltacoronavirus [94,95]. However, there"/>
 <result pre="tethered double-membrane spherules was observed in the Gammacoronavirus avian infectious" exact="bronchitis" post="virus [93] and porcine Deltacoronavirus [94,95]. However, there is"/>
 <result pre="is important to study the presence of ROs during coronavirus" exact="infection" post="in hosts. In addition, how the RNA intermediates are"/>
 <result pre="can be dissolved or still exist in the cytosol after" exact="viral" post="RNA synthesis, need to be further elucidated. 4.3. Coronaviruses"/>
 <result pre="signal cascades and expression of ISGs and, consequently, contribute to" exact="viral" post="pathogenesis [65]. Some reports have shown that SARS-CoV encodes"/>
 <result pre="Some reports have shown that SARS-CoV encodes at least 11" exact="viral" post="proteins as IFN antagonists [96], and more than 10"/>
 <result pre="viral proteins as IFN antagonists [96], and more than 10" exact="viral" post="proteins of PEDV have an inhibitory function that is"/>
 <result pre="to suppress the innate immune signaling pathways, of which the" exact="viral" post="protein functions of nonstructural proteins such as nsp1, nsp3,"/>
 <result pre="emphasized in this review (Figure 2). 4.3.1. Shut-Off of Host" exact="Protein" post="Synthesis Some viruses and their protein components can halt"/>
 <result pre="among the four different coronavirus genera. Only the genomes of" exact="Alpha" post="and Betacoronaviruses encode nsp1, and the genomes of Gammacoronaviruses"/>
 <result pre="the translation of host mRNAs. For example, SARS-CoV nsp1 is" exact="localized" post="exclusively in the cytoplasm and directly binds to the"/>
 <result pre="[106]. This indicates that coronavirus PLpro is highly conserved in" exact="viral" post="evolutionary processes and is recognized as an attractive antiviral"/>
 <result pre="is the main proteinase that controls the activities of the" exact="viral" post="replication complex. This protease often exerts unique functions to"/>
 <result pre="PEDV 3CLpro is used for cleaving cellular substrates to promote" exact="viral infection" post="and inhibit the innate immune response through cleavage of"/>
 <result pre="3CLpro is used for cleaving cellular substrates to promote viral" exact="infection" post="and inhibit the innate immune response through cleavage of"/>
 <result pre="(NEMO), resulting in attenuation of the innate immune response to" exact="virus infection" post="[108,109]. PDCoV nsp5 suppresses IFN expression via the cleavage"/>
 <result pre="resulting in attenuation of the innate immune response to virus" exact="infection" post="[108,109]. PDCoV nsp5 suppresses IFN expression via the cleavage"/>
 <result pre="drug target for the treatment of diseases caused by coronavirus" exact="infection" post="[113,114]. 4.3.4. Modification of the 5â€²-Cap Structure to Circumvent"/>
 <result pre="with N7-methylation and 2â€²-O-methylation using enzymes during the transcription process." exact="Viral" post="RNAs without a 5â€²cap structure or methylation should be"/>
 <result pre="and 2â€²-O-methyltransferase (2â€²-O-MTase) encoded in nsp16 [117]. These enzymes provide" exact="viral" post="RNA equipped with 2â€²-O-methylation or N7-methylation, which gives them"/>
 <result pre="IFN production [121]. 5. Therapeutic Approaches for Treatment of COVID-19" exact="Viral" post="replication may be particularly active during the early phrase"/>
 <result pre="exerts its greatest effects before the illness progresses into the" exact="systemic" post="hyperinflammatory stage [122]. Several antiviral drugs (remdesivir, chloroquine, and"/>
 <result pre="have been shown to have an inhibitory effect on controlling" exact="viral infection" post="and replication in patients with COVID-19 [123]. Potential drugs"/>
 <result pre="been shown to have an inhibitory effect on controlling viral" exact="infection" post="and replication in patients with COVID-19 [123]. Potential drugs"/>
 <result pre="replication in patients with COVID-19 [123]. Potential drugs may inhibit" exact="viral" post="entry and replication via targeting the ACE2 receptor and"/>
 <result pre="entry and replication via targeting the ACE2 receptor and TMPRSS2," exact="viral" post="membrane fusion and endocytosis, or the 3CLpro activity of"/>
 <result pre="a triple combination of IFNÎ²-1b, lopinavir-ritonavir, and ribavirin showed faster" exact="viral" post="clearance and more rapid clinical improvement compared with the"/>
 <result pre="A summary of the action of these agents against SARS-CoV-2" exact="infection" post="is shown in Table 1. Besides the pharmacologic interventions,"/>
 <result pre="and cause illnesses associated with their vial tropism in the" exact="respiratory" post="tract and/or intestinal tract. A myriad of epithelial cells"/>
 <result pre="in the respiratory tract and/or intestinal tract. A myriad of" exact="epithelial" post="cells and innate immune cells exert a set of"/>
 <result pre="coronaviruses can delay IFN production during the early phase of" exact="viral infection" post="and induce hyperactive inflammatory responses in the advanced stages,"/>
 <result pre="can delay IFN production during the early phase of viral" exact="infection" post="and induce hyperactive inflammatory responses in the advanced stages,"/>
 <result pre="tissue organoids are close to the real scenario in the" exact="respiratory" post="and intestinal tracts and can be applied in vitro"/>
 <result pre="tyrosine kinase 2 AKK1 adaptor-associated kinase-1 References References 1.PeirisJ.S.YuenK.Y.OsterhausA.D.StohrK.The severe" exact="acute" post="respiratory syndromeN. Engl. J. Med.20033492431244110.1056/NEJMra03249814681510 2.De GrootR.J.BakerS.C.BaricR.S.BrownC.S.DrostenC.EnjuanesL.FouchierR.A.GalianoM.GorbalenyaA.E.MemishZ.A.et al.Middle east"/>
 <result pre="kinase 2 AKK1 adaptor-associated kinase-1 References References 1.PeirisJ.S.YuenK.Y.OsterhausA.D.StohrK.The severe acute" exact="respiratory" post="syndromeN. Engl. J. Med.20033492431244110.1056/NEJMra03249814681510 2.De GrootR.J.BakerS.C.BaricR.S.BrownC.S.DrostenC.EnjuanesL.FouchierR.A.GalianoM.GorbalenyaA.E.MemishZ.A.et al.Middle east respiratory"/>
 <result pre="acute respiratory syndromeN. Engl. J. Med.20033492431244110.1056/NEJMra03249814681510 2.De GrootR.J.BakerS.C.BaricR.S.BrownC.S.DrostenC.EnjuanesL.FouchierR.A.GalianoM.GorbalenyaA.E.MemishZ.A.et al.Middle east" exact="respiratory" post="syndrome coronavirus (MERS-CoV): Announcement of the coronavirus study groupJ."/>
 <result pre="respiratory syndromeN. Engl. J. Med.20033492431244110.1056/NEJMra03249814681510 2.De GrootR.J.BakerS.C.BaricR.S.BrownC.S.DrostenC.EnjuanesL.FouchierR.A.GalianoM.GorbalenyaA.E.MemishZ.A.et al.Middle east respiratory" exact="syndrome" post="coronavirus (MERS-CoV): Announcement of the coronavirus study groupJ. Virol.2013877790779210.1128/JVI.01244-1323678167"/>
 <result pre="of the coronavirus study groupJ. Virol.2013877790779210.1128/JVI.01244-1323678167 3.World Health Organization, Coronavirus" exact="Disease" post="(COVID-19) PandemicAvailable online: https://www.who.int/emergencies/diseases/novel-coronavirus-2019(accessed on 30 August 2020) 4.WongL.Y.R.LuiP.Y.JinD.Y.A"/>
 <result pre="response and emerging human coronavirusesVirol. Sin.201631122310.1007/s12250-015-3683-326786772 5.LeeA.J.AshkarA.A.The dual nature of" exact="Type I" post="and Type II interferonsFront. Immunol.20189206110.3389/fimmu.2018.0206130254639 6.WeiH.WangS.ChenQ.ChenY.ChiX.ZhangL.HuangS.GaoG.F.ChenJ.L.Suppression of interferon lambda"/>
 <result pre="human coronavirusesVirol. Sin.201631122310.1007/s12250-015-3683-326786772 5.LeeA.J.AshkarA.A.The dual nature of Type I and" exact="Type II" post="interferonsFront. Immunol.20189206110.3389/fimmu.2018.0206130254639 6.WeiH.WangS.ChenQ.ChenY.ChiX.ZhangL.HuangS.GaoG.F.ChenJ.L.Suppression of interferon lambda signaling by SOCS-1"/>
 <result pre="Pathog.201410e100384510.1371/journal.ppat.100384524391501 7.BroggiA.GhoshS.SpositoB.SpreaficoR.BalzariniF.Lo CascioA.ClementiN.De SantisM.ManciniN.GranucciF.et al.Type III interferons disrupt the lung" exact="epithelial" post="barrier upon viral recognitionScience202036970671210.1126/science.abc354532527925 8.MajorJ.CrottaS.LlorianM.McCabeT.M.GadH.H.PriestnallS.L.HartmannR.WackA.Type I and III interferons"/>
 <result pre="SantisM.ManciniN.GranucciF.et al.Type III interferons disrupt the lung epithelial barrier upon" exact="viral" post="recognitionScience202036970671210.1126/science.abc354532527925 8.MajorJ.CrottaS.LlorianM.McCabeT.M.GadH.H.PriestnallS.L.HartmannR.WackA.Type I and III interferons disrupt lung epithelial"/>
 <result pre="upon viral recognitionScience202036970671210.1126/science.abc354532527925 8.MajorJ.CrottaS.LlorianM.McCabeT.M.GadH.H.PriestnallS.L.HartmannR.WackA.Type I and III interferons disrupt lung" exact="epithelial" post="repair during recovery from viral infectionScience202036971271710.1126/science.abc206132527928 9.ChannappanavarR.FehrA.R.VijayR.MackM.ZhaoJ.MeyerholzD.K.PerlmanS.Dysregulated type I"/>
 <result pre="and III interferons disrupt lung epithelial repair during recovery from" exact="viral" post="infectionScience202036971271710.1126/science.abc206132527928 9.ChannappanavarR.FehrA.R.VijayR.MackM.ZhaoJ.MeyerholzD.K.PerlmanS.Dysregulated type I interferon and inflammatory monocyte-macrophage responses"/>
 <result pre="disrupt lung epithelial repair during recovery from viral infectionScience202036971271710.1126/science.abc206132527928 9.ChannappanavarR.FehrA.R.VijayR.MackM.ZhaoJ.MeyerholzD.K.PerlmanS.Dysregulated" exact="type I" post="interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in"/>
 <result pre="9.ChannappanavarR.FehrA.R.VijayR.MackM.ZhaoJ.MeyerholzD.K.PerlmanS.Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal" exact="pneumonia" post="in SARS-CoV-infected miceCell Host Microbe20161918119310.1016/j.chom.2016.01.00726867177 10.LiL.FuF.GuoS.S.WangH.F.HeX.J.XueM.YinL.D.FengL.LiuP.H.Porcine intestinal enteroids: A"/>
 <result pre="enteroids: A new model for studying enteric coronavirus porcine epidemic" exact="diarrhea" post="virus infection and the host innate responseJ. Virol.201993e01682-1810.1128/JVI.01682-1830541861 11.CaoX.COVID-19:"/>
 <result pre="A new model for studying enteric coronavirus porcine epidemic diarrhea" exact="virus infection" post="and the host innate responseJ. Virol.201993e01682-1810.1128/JVI.01682-1830541861 11.CaoX.COVID-19: Immunopathology and"/>
 <result pre="new model for studying enteric coronavirus porcine epidemic diarrhea virus" exact="infection" post="and the host innate responseJ. Virol.201993e01682-1810.1128/JVI.01682-1830541861 11.CaoX.COVID-19: Immunopathology and"/>
 <result pre="infected with 2019 novel coronavirus in Wuhan, ChinaLancet202039549750610.1016/S0140-6736(20)30183-531986264 13.LiG.FanY.H.LaiY.N.HanT.T.LiZ.H.ZhouP.W.PanP.WangW.B.HuD.W.LiuX.H.et al.Coronavirus" exact="infections" post="and immune responsesJ. Med. Virol.20209242443210.1002/jmv.2568531981224 14.WangQ.VlasovaA.N.KenneyS.P.SaifL.J.Emerging and re-emerging coronaviruses"/>
 <result pre="coronavirusesAdv. Virus Res.20066619329216877062 16.ZhangQ.YooD.Immune evasion of porcine enteric coronaviruses and" exact="viral" post="modulation of antiviral innate signalingVirus Res.201622612814110.1016/j.virusres.2016.05.01527212682 17.SuS.WongG.ShiW.LiuJ.LaiA.C.K.ZhouJ.LiuW.BiY.GaoG.F.Epidemiology, genetic recombination,"/>
 <result pre="19.YeZ.W.YuanS.YuenK.S.FungS.Y.ChanC.P.JinD.Y.Zoonotic origins of human coronavirusesInt. J. Biol. Sci.2020161686169710.7150/ijbs.4547232226286 20.ZhouP.YangX.L.WangX.G.HuB.ZhangL.ZhangW.SiH.R.ZhuY.LiB.HuangC.L.et al.A" exact="pneumonia" post="outbreak associated with a new coronavirus of probable bat"/>
 <result pre="bat originNature202057927027310.1038/s41586-020-2012-732015507 21.HuangY.W.DickermanA.W.PineyroP.LiL.FangL.KiehneR.OpriessnigT.MengX.J.Origin, evolution, and genotyping of emergent porcine epidemic" exact="diarrhea" post="virus strains in the United StatesmBio20134e00737-1310.1128/mBio.00737-1324129257 22.LeeS.LeeC.Complete genome characterization"/>
 <result pre="of SARS-CoV-2 by full-length human ACE2Science20203671444144810.1126/science.abb276232132184 26.TeN.Vergara-AlertJ.LehmbeckerA.PerezM.HaagmansB.L.BaumgartnerW.BensaidA.SegalesJ.Co-localization of Middle East" exact="respiratory" post="syndrome coronavirus (MERS-CoV) and dipeptidyl peptidase-4 in the respiratory"/>
 <result pre="SARS-CoV-2 by full-length human ACE2Science20203671444144810.1126/science.abb276232132184 26.TeN.Vergara-AlertJ.LehmbeckerA.PerezM.HaagmansB.L.BaumgartnerW.BensaidA.SegalesJ.Co-localization of Middle East respiratory" exact="syndrome" post="coronavirus (MERS-CoV) and dipeptidyl peptidase-4 in the respiratory tract"/>
 <result pre="East respiratory syndrome coronavirus (MERS-CoV) and dipeptidyl peptidase-4 in the" exact="respiratory" post="tract and lymphoid tissues of pigs and llamasTransbound Emerg."/>
 <result pre="Natl. Acad. Sci. USA2018115E5135E514310.1073/pnas.180287911529760102 28.WangB.LiuY.JiC.M.YangY.L.LiangQ.Z.ZhaoP.XuL.D.LeiX.M.LuoW.T.QinP.et al.Porcine deltacoronavirus engages the transmissible" exact="gastroenteritis" post="virus functional receptor porcine aminopeptidase N for infectious cellular"/>
 <result pre="the transmissible gastroenteritis virus functional receptor porcine aminopeptidase N for" exact="infectious" post="cellular entryJ. Virol.20189200318-1810.1128/JVI.00318-18 29.StoianA.RowlandR.R.R.PetrovanV.SheahanM.SamuelM.S.WhitworthK.M.WellsK.D.ZhangJ.BeatonB.CiganM.et al.The use of cells from"/>
 <result pre="An analysis of single-cell coexpression pattern of key proteins in" exact="viral" post="entry processGut2020691010101810.1136/gutjnl-2020-320953 32.ZieglerC.G.K.AllonS.J.NyquistS.K.MbanoI.M.MiaoV.N.TzouanasC.N.CaoY.M.YousifA.S.BalsJ.HauserB.M.et al.SARS-CoV-2 receptor ACE2 is an interferon-stimulated"/>
 <result pre="al.SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway" exact="epithelial" post="cells and is detected in specific cell subsets across"/>
 <result pre="al.Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected" exact="disease" post="2019 (COVID-19) with gastrointestinal symptomsGut2020691002100910.1136/gutjnl-2020-32092632213556 34.LinL.JiangX.ZhangZ.HuangS.ZhangZ.FangZ.GuZ.GaoL.ShiH.MaiL.et al.Gastrointestinal symptoms of"/>
 <result pre="Ther.202058410.1038/s41392-020-0191-132467561 37.HanssonG.C.Mucus and mucins in diseases of the intestinal and" exact="respiratory" post="tractsJ. Intern. Med.201928547949010.1111/joim.1291030963635 38.ZaninM.BaviskarP.WebsterR.WebbyR.The interaction between respiratory pathogens and"/>
 <result pre="the intestinal and respiratory tractsJ. Intern. Med.201928547949010.1111/joim.1291030963635 38.ZaninM.BaviskarP.WebsterR.WebbyR.The interaction between" exact="respiratory" post="pathogens and mucusCell Host Microbe20161915916810.1016/j.chom.2016.01.00126867175 39.McCauleyH.A.GuaschG.Three cheers for the"/>
 <result pre="DierenB.LangY.et al.Identification of sialic acid-binding function for the Middle East" exact="respiratory" post="syndrome coronavirus spike glycoproteinProc. Natl. Acad. Sci. USA2017114E8508E851710.1073/pnas.171259211428923942 42.JungK.SaifL.J.Goblet"/>
 <result pre="al.Identification of sialic acid-binding function for the Middle East respiratory" exact="syndrome" post="coronavirus spike glycoproteinProc. Natl. Acad. Sci. USA2017114E8508E851710.1073/pnas.171259211428923942 42.JungK.SaifL.J.Goblet cell"/>
 <result pre="of conventional nursing and weaned pigs infected with porcine epidemic" exact="diarrhea" post="virusRes. Vet. Sci.2017110121510.1016/j.rvsc.2016.10.00928159230 43.ChenX.LiuS.GorayaM.U.MaaroufM.HuangS.ChenJ.L.Host immune response to influenza A"/>
 <result pre="and innate immunityCell200612478380110.1016/j.cell.2006.02.01516497588 45.ZhangQ.KeH.BlikslagerA.FujitaT.YooD.Type III interferon restriction by porcine epidemic" exact="diarrhea" post="virus and the role of viral protein nsp1 in"/>
 <result pre="restriction by porcine epidemic diarrhea virus and the role of" exact="viral" post="protein nsp1 in IRF1 signalingJ. Virol.201892e01677-1710.1128/JVI.01677-1729187542 46.KawaiT.AkiraS.The role of"/>
 <result pre="Toll-like receptorsNat. Immunol.20101137338410.1038/ni.186320404851 47.NazA.ShahidF.ButtT.T.AwanF.M.AliA.MalikA.Designing multi-epitope vaccines to combat emerging coronavirus" exact="disease" post="2019 (COVID-19) by employing immuno-informatics approachFront. Immunol.202011166310.3389/fimmu.2020.0166332754160 48.MarchantD.SingheraG.K.UtokaparchS.HackettT.L.BoydJ.H.LuoZ.S.SiX.N.DorscheidD.R.McManusB.M.HegeleR.G.Toll-like receptor"/>
 <result pre="activation of p38 mitogen-activated protein kinase is a determinant of" exact="respiratory" post="virus entry and tropismJ. Virol.201084113591137310.1128/JVI.00804-1020702616 49.KhanolkarA.HartwigS.M.HaagB.A.MeyerholzD.K.HartyJ.T.VargaS.M.TLR4-deficiency increases disease and"/>
 <result pre="determinant of respiratory virus entry and tropismJ. Virol.201084113591137310.1128/JVI.00804-1020702616 49.KhanolkarA.HartwigS.M.HaagB.A.MeyerholzD.K.HartyJ.T.VargaS.M.TLR4-deficiency increases" exact="disease" post="and mortality after MHV-1 infection in susceptible C3H miceJ."/>
 <result pre="and tropismJ. Virol.201084113591137310.1128/JVI.00804-1020702616 49.KhanolkarA.HartwigS.M.HaagB.A.MeyerholzD.K.HartyJ.T.VargaS.M.TLR4-deficiency increases disease and mortality after MHV-1" exact="infection" post="in susceptible C3H miceJ. Virol.2009838946895610.1128/JVI.01857-0819553337 50.ToturaA.L.WhitmoreA.AgnihothramS.SchaferA.KatzeM.G.HeiseM.T.BaricR.S.Toll-like receptor 3 signaling"/>
 <result pre="TRIF contributes to a protective innate immune response to severe" exact="acute" post="respiratory syndrome coronavirus infectionmBio20156e00638-1510.1128/mBio.00638-1526015500 51.TomaselloE.NaciriK.ChelbiR.BessouG.FriesA.GressierE.AbbasA.PolletE.PierreP.LawrenceT.et al.Molecular dissection of plasmacytoid"/>
 <result pre="contributes to a protective innate immune response to severe acute" exact="respiratory" post="syndrome coronavirus infectionmBio20156e00638-1510.1128/mBio.00638-1526015500 51.TomaselloE.NaciriK.ChelbiR.BessouG.FriesA.GressierE.AbbasA.PolletE.PierreP.LawrenceT.et al.Molecular dissection of plasmacytoid dendritic"/>
 <result pre="to a protective innate immune response to severe acute respiratory" exact="syndrome" post="coronavirus infectionmBio20156e00638-1510.1128/mBio.00638-1526015500 51.TomaselloE.NaciriK.ChelbiR.BessouG.FriesA.GressierE.AbbasA.PolletE.PierreP.LawrenceT.et al.Molecular dissection of plasmacytoid dendritic cell"/>
 <result pre="dissection of plasmacytoid dendritic cell activation in vivo during a" exact="viral" post="infectionEMBO J.201837e9883610.15252/embj.20179883630131424 52.Cervantes-BarraganL.ZustR.WeberF.SpiegelM.LangK.S.AkiraS.ThielV.LudewigB.Control of coronavirus infection through plasmacytoid dendritic-cell-derived"/>
 <result pre="in vivo during a viral infectionEMBO J.201837e9883610.15252/embj.20179883630131424 52.Cervantes-BarraganL.ZustR.WeberF.SpiegelM.LangK.S.AkiraS.ThielV.LudewigB.Control of coronavirus" exact="infection" post="through plasmacytoid dendritic-cell-derived type I interferonBlood20071091131113710.1182/blood-2006-05-02377016985170 53.Moreno-EutimioM.A.Lopez-MaciasC.Pastelin-PalaciosR.Bioinformatic analysis and"/>
 <result pre="viral infectionEMBO J.201837e9883610.15252/embj.20179883630131424 52.Cervantes-BarraganL.ZustR.WeberF.SpiegelM.LangK.S.AkiraS.ThielV.LudewigB.Control of coronavirus infection through plasmacytoid dendritic-cell-derived" exact="type I" post="interferonBlood20071091131113710.1182/blood-2006-05-02377016985170 53.Moreno-EutimioM.A.Lopez-MaciasC.Pastelin-PalaciosR.Bioinformatic analysis and identification of single-stranded RNA sequences"/>
 <result pre="in the SARS-CoV-2, SARS-CoV, and MERS-CoV genomesMicrobes Infect.20202222622910.1016/j.micinf.2020.04.00932361001 54.CaoL.GeX.GaoY.RenY.RenX.LiG.Porcine epidemic" exact="diarrhea" post="virus infection induces NF-kappaB activation through the TLR2, TLR3"/>
 <result pre="the SARS-CoV-2, SARS-CoV, and MERS-CoV genomesMicrobes Infect.20202222622910.1016/j.micinf.2020.04.00932361001 54.CaoL.GeX.GaoY.RenY.RenX.LiG.Porcine epidemic diarrhea" exact="virus infection" post="induces NF-kappaB activation through the TLR2, TLR3 and TLR9"/>
 <result pre="SARS-CoV-2, SARS-CoV, and MERS-CoV genomesMicrobes Infect.20202222622910.1016/j.micinf.2020.04.00932361001 54.CaoL.GeX.GaoY.RenY.RenX.LiG.Porcine epidemic diarrhea virus" exact="infection" post="induces NF-kappaB activation through the TLR2, TLR3 and TLR9"/>
 <result pre="through the TLR2, TLR3 and TLR9 pathways in porcine intestinal" exact="epithelial" post="cellsJ. Gen. Virol.2015961757176710.1099/vir.0.00013325814121 55.ChenS.LuoG.YangZ.LinS.ChenS.WangS.GorayaM.U.ChiX.ZengX.ChenJ.L.Avian Tembusu virus infection effectively triggers"/>
 <result pre="pathways in porcine intestinal epithelial cellsJ. Gen. Virol.2015961757176710.1099/vir.0.00013325814121 55.ChenS.LuoG.YangZ.LinS.ChenS.WangS.GorayaM.U.ChiX.ZengX.ChenJ.L.Avian Tembusu" exact="virus infection" post="effectively triggers host innate immune response through MDA5 and"/>
 <result pre="in porcine intestinal epithelial cellsJ. Gen. Virol.2015961757176710.1099/vir.0.00013325814121 55.ChenS.LuoG.YangZ.LinS.ChenS.WangS.GorayaM.U.ChiX.ZengX.ChenJ.L.Avian Tembusu virus" exact="infection" post="effectively triggers host innate immune response through MDA5 and"/>
 <result pre="and its perturbation by influenza virusesProtein Cell2015671272110.1007/s13238-015-0191-z26206138 57.LiJ.LiuY.ZhangX.Murine coronavirus induces" exact="type I" post="interferon in oligodendrocytes through recognition by RIG-I and MDA5J."/>
 <result pre="and MDA5J. Virol.2010846472648210.1128/JVI.00016-1020427526 58.ZalingerZ.B.ElliottR.RoseK.M.WeissS.R.MDA5 is critical to host defense during" exact="infection" post="with murine coronavirusJ. Virol.201589123301234010.1128/JVI.01470-1526423942 59.YoshikawaT.HillT.E.YoshikawaN.PopovV.L.GalindoC.L.GarnerH.R.PetersC.J.TsengC.T.Dynamic innate immune responses of"/>
 <result pre="murine coronavirusJ. Virol.201589123301234010.1128/JVI.01470-1526423942 59.YoshikawaT.HillT.E.YoshikawaN.PopovV.L.GalindoC.L.GarnerH.R.PetersC.J.TsengC.T.Dynamic innate immune responses of human bronchial" exact="epithelial" post="cells to severe acute respiratory syndrome-associated coronavirus infectionPLoS ONE20105e872910.1371/journal.pone.000872920090954"/>
 <result pre="innate immune responses of human bronchial epithelial cells to severe" exact="acute" post="respiratory syndrome-associated coronavirus infectionPLoS ONE20105e872910.1371/journal.pone.000872920090954 60.LuR.ZhaoX.LiJ.NiuP.YangB.WuH.WangW.SongH.HuangB.ZhuN.et al.Genomic characterisation and"/>
 <result pre="immune responses of human bronchial epithelial cells to severe acute" exact="respiratory" post="syndrome-associated coronavirus infectionPLoS ONE20105e872910.1371/journal.pone.000872920090954 60.LuR.ZhaoX.LiJ.NiuP.YangB.WuH.WangW.SongH.HuangB.ZhuN.et al.Genomic characterisation and epidemiology"/>
 <result pre="receptor bindingLancet202039556557410.1016/S0140-6736(20)30251-832007145 61.ToturaA.L.BaricR.S.SARS coronavirus pathogenesis: Host innate immune responses and" exact="viral" post="antagonism of interferonCurr. Opin. Virol.2012226427510.1016/j.coviro.2012.04.00422572391 62.ZhouJ.H.WangY.N.ChangQ.Y.MaP.HuY.CaoX.Type III interferons in"/>
 <result pre="viral antagonism of interferonCurr. Opin. Virol.2012226427510.1016/j.coviro.2012.04.00422572391 62.ZhouJ.H.WangY.N.ChangQ.Y.MaP.HuY.CaoX.Type III interferons in" exact="viral infection" post="and antiviral immunityCell Physiol. Biochem.20185117318510.1159/00049517230439714 63.CaiB.BaiQ.ChiX.GorayaM.U.WangL.WangS.ChenB.ChenJ.L.Infection with classical swine"/>
 <result pre="antagonism of interferonCurr. Opin. Virol.2012226427510.1016/j.coviro.2012.04.00422572391 62.ZhouJ.H.WangY.N.ChangQ.Y.MaP.HuY.CaoX.Type III interferons in viral" exact="infection" post="and antiviral immunityCell Physiol. Biochem.20185117318510.1159/00049517230439714 63.CaiB.BaiQ.ChiX.GorayaM.U.WangL.WangS.ChenB.ChenJ.L.Infection with classical swine"/>
 <result pre="Biochem.20185117318510.1159/00049517230439714 63.CaiB.BaiQ.ChiX.GorayaM.U.WangL.WangS.ChenB.ChenJ.L.Infection with classical swine fever virus induces expression of" exact="Type III" post="interferons and activates innate immune signalingFront. Microbiol.20178255810.3389/fmicb.2017.0255829312239 64.MahlakoivT.HernandezP.GronkeK.DiefenbachA.StaeheliP.Leukocyte-derived IFN-alpha/beta"/>
 <result pre="interferons and activates innate immune signalingFront. Microbiol.20178255810.3389/fmicb.2017.0255829312239 64.MahlakoivT.HernandezP.GronkeK.DiefenbachA.StaeheliP.Leukocyte-derived IFN-alpha/beta and" exact="epithelial" post="IFN-lambda constitute a compartmentalized mucosal defense system that restricts"/>
 <result pre="restricts enteric virus infectionsPLoS Pathog.201511e100478210.1371/journal.ppat.100478225849543 65.KikkertM.Innate immune evasion by human" exact="respiratory" post="RNA virusesJ. Innate Immun.20201242010.1159/00050303031610541 66.ZieglerT.MatikainenS.RonkkoE.OsterlundP.SillanpaaM.SirenJ.FagerlundR.ImmonenM.MelenK.JulkunenI.Severe acute respiratory syndrome coronavirus"/>
 <result pre="immune evasion by human respiratory RNA virusesJ. Innate Immun.20201242010.1159/00050303031610541 66.ZieglerT.MatikainenS.RonkkoE.OsterlundP.SillanpaaM.SirenJ.FagerlundR.ImmonenM.MelenK.JulkunenI.Severe" exact="acute" post="respiratory syndrome coronavirus fails to activate cytokine-mediated innate immune"/>
 <result pre="evasion by human respiratory RNA virusesJ. Innate Immun.20201242010.1159/00050303031610541 66.ZieglerT.MatikainenS.RonkkoE.OsterlundP.SillanpaaM.SirenJ.FagerlundR.ImmonenM.MelenK.JulkunenI.Severe acute" exact="respiratory" post="syndrome coronavirus fails to activate cytokine-mediated innate immune responses"/>
 <result pre="by human respiratory RNA virusesJ. Innate Immun.20201242010.1159/00050303031610541 66.ZieglerT.MatikainenS.RonkkoE.OsterlundP.SillanpaaM.SirenJ.FagerlundR.ImmonenM.MelenK.JulkunenI.Severe acute respiratory" exact="syndrome" post="coronavirus fails to activate cytokine-mediated innate immune responses in"/>
 <result pre="SARS coronavirusVirol. J.200631710.1186/1743-422X-3-1716571117 68.ZhouZ.RenL.ZhangL.ZhongJ.XiaoY.JiaZ.GuoL.YangJ.WangC.JiangS.et al.Heightened innate immune responses in the" exact="respiratory" post="tract of COVID-19 patientsCell Host Microbe202027883890.e210.1016/j.chom.2020.04.01732407669 69.OngE.Z.Y.ChanY.F.Z.LeongW.Y.LeeN.M.Y.KalimuddinS.MohideenS.M.H.ChanK.S.TanA.T.BertolettiA.OoiE.E.et al.A dynamic"/>
 <result pre="response shapes COVID-19 progressionCell Host Microbe20202787988210.1016/j.chom.2020.03.02132359396 70.Prokunina-OlssonL.AlphonseN.DickensonR.E.DurbinJ.E.GlennJ.S.HartmannR.KotenkoS.V.LazearH.M.Oâ€™BrienT.R.OdendallC.et al.COVID-19 and emerging" exact="viral" post="infections: The case for interferon lambdaJ. Exp. Med.2020217e2020065310.1084/jem.2020065332289152 71.Haji"/>
 <result pre="non-severe COVID-19Nat. Med.20202645345510.1038/s41591-020-0819-232284614 76.RaiK.R.ChenB.ZhaoZ.ChenY.HuJ.LiuS.MaaroufM.LiY.XiaoM.LiaoY.et al.Robust expression of p27Kip1 induced by" exact="viral infection" post="is critical for antiviral innate immunityCell Microbiol.2020e1324210.1111/cmi.1324232596986 77.PerngY.C.LenschowD.J.ISG15 in"/>
 <result pre="COVID-19Nat. Med.20202645345510.1038/s41591-020-0819-232284614 76.RaiK.R.ChenB.ZhaoZ.ChenY.HuJ.LiuS.MaaroufM.LiY.XiaoM.LiaoY.et al.Robust expression of p27Kip1 induced by viral" exact="infection" post="is critical for antiviral innate immunityCell Microbiol.2020e1324210.1111/cmi.1324232596986 77.PerngY.C.LenschowD.J.ISG15 in"/>
 <result pre="influenza A virusPLoS Pathog.20117e100125810.1371/journal.ppat.100125821253575 81.WilkA.J.RustagiA.ZhaoN.Q.RoqueJ.Martinez-ColonG.J.McKechnieJ.L.IvisonG.T.RanganathT.VergaraR.HollisT.et al.A single-cell atlas of the" exact="peripheral" post="immune response in patients with severe COVID-19Nat. Med.2020261070107610.1038/s41591-020-0944-y32514174 82.WuZ.McGooganJ.M.Characteristics"/>
 <result pre="COVID-19Nat. Med.2020261070107610.1038/s41591-020-0944-y32514174 82.WuZ.McGooganJ.M.Characteristics of and important lessons from the coronavirus" exact="disease" post="2019 (COVID-19) outbreak in China: Summary of a report"/>
 <result pre="a report of 72314 cases from the chinese center for" exact="disease" post="control and preventionJAMA20203231239124210.1001/jama.2020.264832091533 83.ZouL.RuanF.HuangM.LiangL.HuangH.HongZ.YuJ.KangM.SongY.XiaJ.et al.SARS-CoV-2 viral load in upper"/>
 <result pre="the chinese center for disease control and preventionJAMA20203231239124210.1001/jama.2020.264832091533 83.ZouL.RuanF.HuangM.LiangL.HuangH.HongZ.YuJ.KangM.SongY.XiaJ.et al.SARS-CoV-2" exact="viral" post="load in upper respiratory specimens of infected patientsN. Engl."/>
 <result pre="for disease control and preventionJAMA20203231239124210.1001/jama.2020.264832091533 83.ZouL.RuanF.HuangM.LiangL.HuangH.HongZ.YuJ.KangM.SongY.XiaJ.et al.SARS-CoV-2 viral load in" exact="upper" post="respiratory specimens of infected patientsN. Engl. J. Med.20203821177117910.1056/NEJMc200173732074444 84.YangZ.Y.HuangY.GaneshL.LeungK.KongW.P.SchwartzO.SubbaraoK.NabelG.J.pH-dependent"/>
 <result pre="disease control and preventionJAMA20203231239124210.1001/jama.2020.264832091533 83.ZouL.RuanF.HuangM.LiangL.HuangH.HongZ.YuJ.KangM.SongY.XiaJ.et al.SARS-CoV-2 viral load in upper" exact="respiratory" post="specimens of infected patientsN. Engl. J. Med.20203821177117910.1056/NEJMc200173732074444 84.YangZ.Y.HuangY.GaneshL.LeungK.KongW.P.SchwartzO.SubbaraoK.NabelG.J.pH-dependent entry"/>
 <result pre="of infected patientsN. Engl. J. Med.20203821177117910.1056/NEJMc200173732074444 84.YangZ.Y.HuangY.GaneshL.LeungK.KongW.P.SchwartzO.SubbaraoK.NabelG.J.pH-dependent entry of severe" exact="acute" post="respiratory syndrome coronavirus is mediated by the spike glycoprotein"/>
 <result pre="infected patientsN. Engl. J. Med.20203821177117910.1056/NEJMc200173732074444 84.YangZ.Y.HuangY.GaneshL.LeungK.KongW.P.SchwartzO.SubbaraoK.NabelG.J.pH-dependent entry of severe acute" exact="respiratory" post="syndrome coronavirus is mediated by the spike glycoprotein and"/>
 <result pre="patientsN. Engl. J. Med.20203821177117910.1056/NEJMc200173732074444 84.YangZ.Y.HuangY.GaneshL.LeungK.KongW.P.SchwartzO.SubbaraoK.NabelG.J.pH-dependent entry of severe acute respiratory" exact="syndrome" post="coronavirus is mediated by the spike glycoprotein and enhanced"/>
 <result pre="pathway of enteric PEDV dissemination from nasal cavity to intestinal" exact="mucosa" post="in swineNat. Commun.2018911410.1038/s41467-018-06056-w29317637 88.ChuH.ZhouJ.WongB.H.LiC.ChengZ.S.LinX.PoonV.K.SunT.LauC.C.ChanJ.F.et al.Productive replication of middle east"/>
 <result pre="mucosa in swineNat. Commun.2018911410.1038/s41467-018-06056-w29317637 88.ChuH.ZhouJ.WongB.H.LiC.ChengZ.S.LinX.PoonV.K.SunT.LauC.C.ChanJ.F.et al.Productive replication of middle east" exact="respiratory" post="syndrome coronavirus in monocyte-derived dendritic cells modulates innate immune"/>
 <result pre="in swineNat. Commun.2018911410.1038/s41467-018-06056-w29317637 88.ChuH.ZhouJ.WongB.H.LiC.ChengZ.S.LinX.PoonV.K.SunT.LauC.C.ChanJ.F.et al.Productive replication of middle east respiratory" exact="syndrome" post="coronavirus in monocyte-derived dendritic cells modulates innate immune responseVirology201445419720510.1016/j.virol.2014.02.01824725946"/>
 <result pre="in monocyte-derived dendritic cells modulates innate immune responseVirology201445419720510.1016/j.virol.2014.02.01824725946 89.NagyP.D.StratingJ.R.van KuppeveldF.J.Building" exact="viral" post="replication organelles: Close encounters of the membrane typesPLoS Pathog.201612e100591210.1371/journal.ppat.100591227788266"/>
 <result pre="by a reticulovesicular network of modified endoplasmic reticulumPLoS Biol.200861957197410.1371/journal.pbio.0060226 91.AngeliniM.M.AkhlaghpourM.NeumanB.W.BuchmeierM.J.Severe" exact="acute" post="respiratory syndrome coronavirus nonstructural proteins 3, 4, and 6"/>
 <result pre="a reticulovesicular network of modified endoplasmic reticulumPLoS Biol.200861957197410.1371/journal.pbio.0060226 91.AngeliniM.M.AkhlaghpourM.NeumanB.W.BuchmeierM.J.Severe acute" exact="respiratory" post="syndrome coronavirus nonstructural proteins 3, 4, and 6 induce"/>
 <result pre="reticulovesicular network of modified endoplasmic reticulumPLoS Biol.200861957197410.1371/journal.pbio.0060226 91.AngeliniM.M.AkhlaghpourM.NeumanB.W.BuchmeierM.J.Severe acute respiratory" exact="syndrome" post="coronavirus nonstructural proteins 3, 4, and 6 induce double-membrane"/>
 <result pre="6 induce double-membrane vesiclesmBio20134e00524-1310.1128/mBio.00524-1323943763 92.OudshoornD.RijsK.LimpensR.GroenK.KosterA.J.SnijderE.J.KikkertM.BarcenaM.Expression and cleavage of Middle East" exact="respiratory" post="syndrome coronavirus nsp3-4 polyprotein induce the formation of double-membrane"/>
 <result pre="induce double-membrane vesiclesmBio20134e00524-1310.1128/mBio.00524-1323943763 92.OudshoornD.RijsK.LimpensR.GroenK.KosterA.J.SnijderE.J.KikkertM.BarcenaM.Expression and cleavage of Middle East respiratory" exact="syndrome" post="coronavirus nsp3-4 polyprotein induce the formation of double-membrane vesicles"/>
 <result pre="vesicles that mimic those associated with coronaviral RNA replicationmBio20178e01658-1710.1128/mBio.01658-1729162711 93.MaierH.J.HawesP.C.CottamE.M.MantellJ.VerkadeP.MonaghanP.WilemanT.BrittonP.Infectious" exact="bronchitis" post="virus generates spherules from zippered endoplasmic reticulum membranesmBio20134e00801-1310.1128/mBio.00801-1324149513 94.DoyleN.HawesP.C.SimpsonJ.AdamsL.H.MaierH.J.The"/>
 <result pre="down RNA synthesisPLoS Biol.202018e300071510.1371/journal.pbio.300071532511245 96.KindlerE.ThielV.To sense or not to sense" exact="viral" post="RNA-essentials of coronavirus innate immune evasionCurr. Opin. Microbiol.201420697510.1016/j.mib.2014.05.00524908561 97.ZhangQ.ShiK.YooD.Suppression"/>
 <result pre="RNA-essentials of coronavirus innate immune evasionCurr. Opin. Microbiol.201420697510.1016/j.mib.2014.05.00524908561 97.ZhangQ.ShiK.YooD.Suppression of" exact="type I" post="interferon production by porcine epidemic diarrhea virus and degradation"/>
 <result pre="Microbiol.201420697510.1016/j.mib.2014.05.00524908561 97.ZhangQ.ShiK.YooD.Suppression of type I interferon production by porcine epidemic" exact="diarrhea" post="virus and degradation of CREB-binding protein by nsp1Virology201648925226810.1016/j.virol.2015.12.01026773386 98.HuangC.LokugamageK.G.RozovicsJ.M.NarayananK.SemlerB.L.MakinoS.SARS"/>
 <result pre="98.HuangC.LokugamageK.G.RozovicsJ.M.NarayananK.SemlerB.L.MakinoS.SARS coronavirus nsp1 protein induces template-dependent endonucleolytic cleavage of mRNAs:" exact="Viral" post="mRNAs are resistant to nsp1-induced RNA cleavagePLoS Pathog.20117e100243310.1371/journal.ppat.100243322174690 99.WooP.C.LauS.K.LamC.S.LauC.C.TsangA.K.LauJ.H.BaiR.TengJ.L.TsangC.C.WangM.et"/>
 <result pre="as the gene source of gammacoronavirus and deltacoronavirusJ. Virol.2012863995400822278237 100.LokugamageK.G.NarayananK.HuangC.MakinoS.Severe" exact="acute" post="respiratory syndrome coronavirus protein nsp1 is a novel eukaryotic"/>
 <result pre="the gene source of gammacoronavirus and deltacoronavirusJ. Virol.2012863995400822278237 100.LokugamageK.G.NarayananK.HuangC.MakinoS.Severe acute" exact="respiratory" post="syndrome coronavirus protein nsp1 is a novel eukaryotic translation"/>
 <result pre="gene source of gammacoronavirus and deltacoronavirusJ. Virol.2012863995400822278237 100.LokugamageK.G.NarayananK.HuangC.MakinoS.Severe acute respiratory" exact="syndrome" post="coronavirus protein nsp1 is a novel eukaryotic translation inhibitor"/>
 <result pre="that represses multiple steps of translation initiationJ. Virol.201286135981360810.1128/JVI.01958-1223035226 101.LokugamageK.G.NarayananK.NakagawaK.TerasakiK.RamirezS.I.TsengC.T.MakinoS.Middle east" exact="respiratory" post="syndrome coronavirus nsp1 inhibits host gene expression by selectively"/>
 <result pre="represses multiple steps of translation initiationJ. Virol.201286135981360810.1128/JVI.01958-1223035226 101.LokugamageK.G.NarayananK.NakagawaK.TerasakiK.RamirezS.I.TsengC.T.MakinoS.Middle east respiratory" exact="syndrome" post="coronavirus nsp1 inhibits host gene expression by selectively targeting"/>
 <result pre="immunityJ. Exp. Med.201621311310.1084/jem.2015153126712804 103.SuleaT.LindnerH.A.PurisimaE.O.MenardR.Deubiquitination, a new function of the severe" exact="acute" post="respiratory syndrome coronavirus papain-like protease?J. Virol.2005794550455110.1128/JVI.79.7.4550-4551.200515767458 104.YangX.ChenX.BianG.TuJ.XingY.WangY.ChenZ.Proteolytic processing, deubiquitinase"/>
 <result pre="Exp. Med.201621311310.1084/jem.2015153126712804 103.SuleaT.LindnerH.A.PurisimaE.O.MenardR.Deubiquitination, a new function of the severe acute" exact="respiratory" post="syndrome coronavirus papain-like protease?J. Virol.2005794550455110.1128/JVI.79.7.4550-4551.200515767458 104.YangX.ChenX.BianG.TuJ.XingY.WangY.ChenZ.Proteolytic processing, deubiquitinase and"/>
 <result pre="Med.201621311310.1084/jem.2015153126712804 103.SuleaT.LindnerH.A.PurisimaE.O.MenardR.Deubiquitination, a new function of the severe acute respiratory" exact="syndrome" post="coronavirus papain-like protease?J. Virol.2005794550455110.1128/JVI.79.7.4550-4551.200515767458 104.YangX.ChenX.BianG.TuJ.XingY.WangY.ChenZ.Proteolytic processing, deubiquitinase and interferon"/>
 <result pre="104.YangX.ChenX.BianG.TuJ.XingY.WangY.ChenZ.Proteolytic processing, deubiquitinase and interferon antagonist activities of Middle East" exact="respiratory" post="syndrome coronavirus papain-like proteaseJ. Gen. Virol.20149561462610.1099/vir.0.059014-024362959 105.XingY.ChenJ.TuJ.ZhangB.ChenX.ShiH.BakerS.C.FengL.ChenZ.The papain-like protease"/>
 <result pre="processing, deubiquitinase and interferon antagonist activities of Middle East respiratory" exact="syndrome" post="coronavirus papain-like proteaseJ. Gen. Virol.20149561462610.1099/vir.0.059014-024362959 105.XingY.ChenJ.TuJ.ZhangB.ChenX.ShiH.BakerS.C.FengL.ChenZ.The papain-like protease of"/>
 <result pre="papain-like proteaseJ. Gen. Virol.20149561462610.1099/vir.0.059014-024362959 105.XingY.ChenJ.TuJ.ZhangB.ChenX.ShiH.BakerS.C.FengL.ChenZ.The papain-like protease of porcine epidemic" exact="diarrhea" post="virus negatively regulates type I interferon pathway by acting"/>
 <result pre="105.XingY.ChenJ.TuJ.ZhangB.ChenX.ShiH.BakerS.C.FengL.ChenZ.The papain-like protease of porcine epidemic diarrhea virus negatively regulates" exact="type I" post="interferon pathway by acting as a viral deubiquitinaseJ. Gen."/>
 <result pre="negatively regulates type I interferon pathway by acting as a" exact="viral" post="deubiquitinaseJ. Gen. Virol.2013941554156710.1099/vir.0.051169-023596270 106.LeiJ.KusovY.HilgenfeldR.Nsp3 of coronaviruses: Structures and functions"/>
 <result pre="by novel subsite cooperativityProc. Natl. Acad. Sci. USA2016113129971300210.1073/pnas.160132711327799534 108.WangD.FangL.ShiY.ZhangH.GaoL.PengG.ChenH.LiK.XiaoS.Porcine epidemic" exact="diarrhea" post="virus 3C-like protease regulates its interferon antagonism by cleaving"/>
 <result pre="by cleaving NEMOJ. Virol.2016902090210110.1128/JVI.02514-1526656704 109.YeG.WangX.TongX.ShiY.FuZ.F.PengG.Structural basis for inhibiting porcine epidemic" exact="diarrhea" post="virus replication with the 3C-like protease inhibitor GC376Viruses20201224010.3390/v12020240 110.ZhuX.FangL.WangD.YangY.ChenJ.YeX.FodaM.F.XiaoS.Porcine"/>
 <result pre="through the cleavage of NEMOVirology2017502333810.1016/j.virol.2016.12.00527984784 111.ZhuX.Y.WangD.ZhouJ.W.PanT.ChenJ.Y.YangY.T.LvM.T.YeX.PengG.Q.FangL.R.et al.Porcine deltacoronavirus nsp5 antagonizes" exact="Type I" post="interferon signaling by cleaving STAT2J. Virol.201791e00003-1710.1128/JVI.00003-1728250121 112.St JohnS.E.AnsonB.J.MesecarA.D.X-ray structure"/>
 <result pre="JohnS.E.AnsonB.J.MesecarA.D.X-ray structure and inhibition of 3C-like protease from porcine epidemic" exact="diarrhea" post="virusSci. Rep.201662596110.1038/srep2596127173881 113.AnandK.ZiebuhrJ.WadhwaniP.MestersJ.R.HilgenfeldR.Coronavirus main proteinase (3CLpro) structure: Basis for"/>
 <result pre="the RNA sensor Mda5Nat. Immunol.20111213714310.1038/ni.197921217758 119.DaffisS.SzretterK.J.SchriewerJ.LiJ.YounS.ErrettJ.LinT.Y.SchnellerS.ZustR.DongH.et al.2â€²-O methylation of the" exact="viral" post="mRNA cap evades host restriction by IFIT family membersNature201046845245610.1038/nature0948921085181"/>
 <result pre="family membersNature201046845245610.1038/nature0948921085181 120.ShiP.SuY.LiR.LiangZ.DongS.HuangJ.PEDV nsp16 negatively regulates innate immunity to promote" exact="viral" post="proliferationVirus Res.2019265576610.1016/j.virusres.2019.03.00530849413 121.LuiP.Y.WongL.Y.FungC.L.SiuK.L.YeungM.L.YuenK.S.ChanC.P.WooP.C.YuenK.Y.JinD.Y.Middle East respiratory syndrome coronavirus M protein"/>
 <result pre="regulates innate immunity to promote viral proliferationVirus Res.2019265576610.1016/j.virusres.2019.03.00530849413 121.LuiP.Y.WongL.Y.FungC.L.SiuK.L.YeungM.L.YuenK.S.ChanC.P.WooP.C.YuenK.Y.JinD.Y.Middle East" exact="respiratory" post="syndrome coronavirus M protein suppresses type I interferon expression"/>
 <result pre="innate immunity to promote viral proliferationVirus Res.2019265576610.1016/j.virusres.2019.03.00530849413 121.LuiP.Y.WongL.Y.FungC.L.SiuK.L.YeungM.L.YuenK.S.ChanC.P.WooP.C.YuenK.Y.JinD.Y.Middle East respiratory" exact="syndrome" post="coronavirus M protein suppresses type I interferon expression through"/>
 <result pre="proliferationVirus Res.2019265576610.1016/j.virusres.2019.03.00530849413 121.LuiP.Y.WongL.Y.FungC.L.SiuK.L.YeungM.L.YuenK.S.ChanC.P.WooP.C.YuenK.Y.JinD.Y.Middle East respiratory syndrome coronavirus M protein suppresses" exact="type I" post="interferon expression through the inhibition of TBK1-dependent phosphorylation of"/>
 <result pre="illness in native and immunosuppressed states: A clinical-therapeutic staging proposalJ." exact="Heart" post="Lung Transpl.20203940540710.1016/j.healun.2020.03.012 123.collab: COVID-19 Treatment Guidellines Panel, Coronavirus Disease"/>
 <result pre="proposalJ. Heart Lung Transpl.20203940540710.1016/j.healun.2020.03.012 123.collab: COVID-19 Treatment Guidellines Panel, Coronavirus" exact="Disease" post="2019 (COVID-19) Treatment GuidelinesNatiional Institutes of HealthAvailable online: https://www.covid19treatmentguidelines.nih.gov(accessed"/>
 <result pre="online: https://www.covid19treatmentguidelines.nih.gov(accessed on 27 August 2020) 124.SandersJ.M.MonogueM.L.JodlowskiT.Z.CutrellJ.B.Pharmacologic treatments for coronavirus" exact="disease" post="2019 (COVID-19): A reviewJAMA202010.1001/jama.2020.601932282022 125.AoubaA.BaldolliA.GeffrayL.VerdonR.BergotE.Martin-SilvaN.JustetA.Targeting the inflammatory cascade with"/>
 <result pre="less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2" exact="infection" post="in vitroCell Discov.2020610.1038/s41421-020-0156-0 134.SchoergenhoferC.JilmaB.StimpflT.KarolyiM.ZoufalyA.Pharmacokinetics of lopinavir and ritonavir in"/>
 <result pre="134.SchoergenhoferC.JilmaB.StimpflT.KarolyiM.ZoufalyA.Pharmacokinetics of lopinavir and ritonavir in patients hospitalized with coronavirus" exact="disease" post="2019 (COVID-19)Ann. Intern. Med.2020M20-155010.7326/M20-1550 135.GroupR.C.HorbyP.LimW.S.EmbersonJ.R.MafhamM.BellJ.L.LinsellL.StaplinN.BrightlingC.UstianowskiA.et al.Dexamethasone in hospitalized patients"/>
 <result pre="subpopulationsArthritis Res. Ther.20192118310.1186/s13075-019-1964-131375130 139.CaoY.WeiJ.ZouL.JiangT.WangG.ChenL.HuangL.MengF.HuangL.WangN.et al.Ruxolitinib in treatment of severe coronavirus" exact="disease" post="2019 (COVID-19): A multicenter, single-blind, randomized controlled trialJ. Allergy"/>
 <result pre="trialJ. Allergy Clin. Immunol.202014613714610.1016/j.jaci.2020.05.01932470486 Figure 1 Architecture of the mucosal" exact="epithelial" post="barrier in the respiratory and intestinal tracts that guards"/>
 <result pre="Figure 1 Architecture of the mucosal epithelial barrier in the" exact="respiratory" post="and intestinal tracts that guards against viral invasion. (A)."/>
 <result pre="barrier in the respiratory and intestinal tracts that guards against" exact="viral" post="invasion. (A). The airway epithelium is composed of ciliated"/>
 <result pre="cells, basal cells, and Clara cells. The mucus on the" exact="epithelial" post="surface is the first barrier against human infection by"/>
 <result pre="on the epithelial surface is the first barrier against human" exact="infection" post="by coronaviruses, such as SARS-CoV, MERS-CoV, and the novel"/>
 <result pre="coronavirus, SARS-CoV-2. The mucins secreted by goblet cells on the" exact="epithelial" post="surface include two layers, a viscous layer on top"/>
 <result pre="such as dendritic cells and macrophages are involved in controlling" exact="viral infection." post="(B) Enteric coronaviruses, such as PEDV and PDCoV, principally"/>
 <result pre="the functional purposes and internal environments of the gut and" exact="respiratory" post="tract. The mucus of the intestinal tract mainly consists"/>
 <result pre="Paneth cells, and plasma cells, respectively. In particular, the commensal" exact="bacterial" post="communities resident in the mucus of the gut are"/>
 <result pre="In addition, the intraepithelial lymphocytes (IELs) are located between intestinal" exact="epithelial" post="cells, and these cells constitute a large and highly"/>
 <result pre="cells constitute a large and highly conserved T cell compartment." exact="Intestinal" post="microfold cells (M cells) are only found in the"/>
 <result pre="are internalized into susceptible target cells by the fusion of" exact="viral" post="and cellular membranes with unique receptors, such as ACE2,"/>
 <result pre="as ACE2, DPP4, and APN, and the RNA of the" exact="viral" post="genome is released into the cytosol. SARS-CoV and SARS-CoV-2"/>
 <result pre="as toll-like receptors (TLRs) and cytoplasm retinoic acid-inducible gene (RIG)" exact="type I" post="like receptors (RLRs) (RIG-I/MDA5). The extracellular membrane of TLRs"/>
 <result pre="TLRs (TLR2/4) and endosome TLRs (TLR3/7/8) are widely expressed in" exact="epithelial" post="cells and dendritic cells. The PAMPs of coronaviruses induce"/>
 <result pre="Activated transcription factors are translocated into the nucleus to promote" exact="Type I" post="and III IFN expression. IFNs are secreted into the"/>
 <result pre="and their antagonists is shown in red boxes. S, severe" exact="acute" post="respiratory symptom coronavirus (SARS-CoV); M, Middle East respiratory syndrome"/>
 <result pre="their antagonists is shown in red boxes. S, severe acute" exact="respiratory" post="symptom coronavirus (SARS-CoV); M, Middle East respiratory syndrome coronavirus"/>
 <result pre="S, severe acute respiratory symptom coronavirus (SARS-CoV); M, Middle East" exact="respiratory" post="syndrome coronavirus (MERS-CoV); P, porcine epidemic diarrhea virus (PEDV);"/>
 <result pre="severe acute respiratory symptom coronavirus (SARS-CoV); M, Middle East respiratory" exact="syndrome" post="coronavirus (MERS-CoV); P, porcine epidemic diarrhea virus (PEDV); PD,"/>
 <result pre="M, Middle East respiratory syndrome coronavirus (MERS-CoV); P, porcine epidemic" exact="diarrhea" post="virus (PEDV); PD, porcine Deltacoronavirus (PDCoV); ACE2, angiotensin-converting enzyme"/>
 <result pre="agents Arbidol Binds Spike protein/ACE2 Inhibits membrane fusion of the" exact="viral" post="envelope [130] Nafacamostat mesylate Inhibits TMPRSS2 Blocks the spread"/>
 <result pre="the spread and pathogenesis of SARS-CoV [131] Chloroquine Hydroxychloroquine Inhibit" exact="viral" post="entry and endocytosis Immunomodulatory effects [132,133] Lopinavir/Ritonavir Inhibits coronavirus"/>
 <result pre="Lopinavir/Ritonavir Inhibits coronavirus 3CLpro activity [134] Remdesivir Ribavirin Favipiravir Binds" exact="viral" post="RdRp, which inhibits viral replication via premature termination of"/>
 <result pre="activity [134] Remdesivir Ribavirin Favipiravir Binds viral RdRp, which inhibits" exact="viral" post="replication via premature termination of RNA transcription [124,132] Corticosteroids"/>
 <result pre="[124,132] Corticosteroids Dexamethasone Methylprednisolone Potential prevention or mitigation of the" exact="systemic" post="inflammatory responses in severe cases of COVID-19 [135] IFNs"/>
 <result pre="Induces transcription of ISGs [71,72] IFN-Î» Binds to IFNALR1/IL10R2 in" exact="epithelial" post="cells and some immune cells Induces transcription of ISGs"/>
 <result pre="Theoretical antiviral properties via inhibition of AKK1 that may prevent" exact="viral" post="entry and infection Inhibition of IL-6 induced STAT3 phosphorylation"/>
 <result pre="via inhibition of AKK1 that may prevent viral entry and" exact="infection" post="Inhibition of IL-6 induced STAT3 phosphorylation [138] Ruxolitinib JAK"/>
 <result pre="Theoretical antiviral activities via inhibition of AKK1 that may prevent" exact="viral" post="entry and infection Inhibition of IL-6 through JAK1/JAK2 pathway"/>
 <result pre="via inhibition of AKK1 that may prevent viral entry and" exact="infection" post="Inhibition of IL-6 through JAK1/JAK2 pathway [139]"/>
</results>
